eXoZymes, Inc. (EXOZ)
4.30
+0.19
(+4.62%)
USD |
NASDAQ |
Nov 06, 10:25
eXoZymes Net Income (Quarterly) : -2.879M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.879M |
| March 31, 2026 | -2.370M |
| December 31, 2025 | -2.655M |
| September 30, 2025 | -2.287M |
| June 30, 2025 | -2.360M |
| March 31, 2025 | -1.856M |
| Date | Value |
|---|---|
| December 31, 2024 | -1.836M |
| September 30, 2024 | -1.656M |
| June 30, 2024 | -1.360M |
| December 31, 2023 | -1.099M |
| December 31, 2022 | -0.3919M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 3.309M |
| Perspective Therapeutics, Inc. | -26.98M |
| MiMedx Group, Inc. | -8.683M |
| ABVC BioPharma, Inc. | -0.8105M |
| Endonovo Therapeutics, Inc. | -0.5884M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.879M |
| EPS Diluted (Quarterly) | -0.3324 |
| Enterprise Value | 33.58M |
| Earnings Yield | -27.95% |
| Normalized Earnings Yield | -28.27 |